Margaret Duggan‐Keen

Author

Also Known As

Core Journal, Duggan-Keen, M, M Duggan-Keen, M F Duggan-Keen, M. Duggan-Keen, M. Duggan‐Keen, M. F. Duggan‐Keen, M.F. Duggan-Keen, Margaret Duggan-Keen, Margaret Duggan‐Keen

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute The Christie NHS Foundation Trust Cancer Research UK University of Liverpool University of Amsterdam

About

Margaret Duggan‐Keen is an author at Cancer Research UK Manchester Institute specializing in medicine, cervical cancer, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Public Health	6	6	637
3	Allergy	2	2	62
4	Cell Biology	2	2	186
5	Epidemiology	1	1	72

Margaret Duggan‐Keen

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer John Ellis, Patrick Keating, J. W. Baird, Nature Medicine VaccinationCervical CancerHpv16 Oncogene VariantHuman Papillomavirus VaccinesImmunology	1995	196
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. El‐Said Abdel‐Hady, Pierre L. Martin‐Hirsch, Margaret Duggan‐Keen, PubMed Vulvar DiseasesCervical CancerSkin CancerPhotodynamic TherapyVulval Intraepithelial Neoplasia	2001	194
Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression PJF Keating, FV Cromme, Margaret Duggan‐Keen, British Journal of Cancer Cervical CancerMedicine-B AllelesTap-1 ExpressionPathology	1995	170
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. Tanja D. de Gruijl, Hetty J. Bontkes, Jan M.M. Walboomers, PubMed 20-Mer PeptidesImmunologyImmunoeditingPathologyCervical Carcinogenesis	1998	120
Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours Peter W. Andrews, Jochen Casper, Ivan Damjanov, International Journal of Cancer	1996	111
HLA class II antigen expression in human papillomavirus-associated cervical cancer. Susan Glew, Margaret Duggan‐Keen, Teresa Cabrera, PubMed HistocompatibilityClass IiHla ImmunogeneticsImmunologyPathology	1992	95
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia Hetty J. Bontkes, Tanja D. de Gruijl, Adrie J.C. van den Muysenberg, International Journal of Cancer ImmunologyGynecologyPathologyCytopathologyImmunotherapy	2000	87
Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer Susan Glew, Margaret Duggan‐Keen, A K Ghosh, Human Immunology Cervical Cancer ScreeningCervical CancerCervical HealthHuman Papillomavirus VaccinesPrecancerous Lesions	1993	72
Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters Claire S. Brady, Margaret Duggan‐Keen, Judith A. Davidson, Journal of General Virology	1999	67
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. Tanja D. de Gruijl, Hetty J. Bontkes, J. M. M. Walboomers, Journal of General Virology Amino AcidsImmunologyPathologyHpv InfectionImmunotherapy	1999	67

Page 1